Table 1.
Molecular docking-based prediction of isoquercitrin and selective gene target complexes against kidney cancer and inflammation [6].
| Compound | Gene Target | Docking Score | Hydrogen Bond | Other Bonds | Docking Structure |
|---|---|---|---|---|---|
| Isoquercitrin | PTGS2 | −9.5 | TYR 136, ASN 34 | PRO 153, CYS 36, ASP 133 |
|
| PIK3CA | −8.4 | GLN 682, LYN 678, SER 464, ASN 428 | ASP 133 |
|
|
| IGF1R | −7.9 | MET 1082, MET 1156, THR 1083 | GLY 1085, ARG 1084, LEU 1005, SER 1089 |
|
|
| IL6 | −7.9 | ALA 177, GLN 144, GLY 43, THR 44 | VAL 94, GLU 157, PRO 176 |
|